Search

Issue
Title
Authors
Conserved linear B-cell peptides among the influenza A viral neuraminidases enhance the cross-protective potential of inactivated whole-virion influenza vaccine
Kotomina T.S., Sychev I.A., Rak A.Y., Wong P., Bazhina A.V., Isakova-Sivak I.N., Rudenko L.G.
Herd immunity to SARS-CoV-2 among the population of the Republic of Belarus amid the COVID-19 pandemic
Popova A.Y., Tarasenko A.A., Smolensky V.Y., Egorova S.A., Smirnov V.S., Dashkevich A.M., Svetogor T.N., Glinskaya I.N., Skuranovich A.L., Milichkina A.M., Dronina A.M., Samoilovich E.O., Khamitova I.V., Semeiko G.V., Amvrosyeva T.V., Shmeleva N.P., Rubanik L.V., Esmanchik O.P., Karaban I.A., Drobyshevskaya V.G., Sadovnikova G.V., Shilovich M.V., Podushkina E.A., Kireichuk V.V., Petrova O.A., Bondarenko S.V., Salazhkova I.F., Tkach L.M., Shepelevich L.P., Autukhova N.L., Ivanov V.M., Babilo A.S., Navyshnaya M.V., Belyaev N.N., Zueva E.V., Volosar L.A., Verbov V.N., Likhachev I.V., Zagorskaya T.O., Morozova N.F., Korobova Z.R., Gubanova A.V., Totolian A.A.
Epidemic influenza virus nucleoprotein gene incorporated into vaccine influenza virus strain genome to optimize systemic and local T-cell immune response against live attenuated influenza vaccine
Prokopenko P.I., Stepanova E.A., Matyushenko V.A., Chistyakova A.K., Kostromitina A.D., Kotomina T.S., Rak A.Y., Rubinstein A.A., Kudryavtsev I.V., Novitskaya V.V., Rudenko L.G., Isakova-Sivak I.N.
Coronavirus spike protein fragment-containing chimeric virus-like particles stimulate human dendritic cell maturation
Talayev V.Y., Novikov D.V., Zaichenko I.Y., Svetlova M.V., Voronina E.V., Babaykina O.N., Lapin V.A., Melentiev D.A., Novikova N.A., Kashnikov A.Y., Novikov V.V.
The impact of adjuvanted and non-adjuvanted influenza vaccines on in vitro lymphocyte immunophenotype
Khromova E.A., Akhmatova N.K., Kostinov M.P., Skhodova S.A., Stolpnikova V.N., Vlasenko A.E., Polishchuk V.B., Shmitko A.D.
Immunograph-based analysis of the influenza a(H1N1)pdm09 vaccine strain immunogenicity in the pandemic and post-pandemic period (2009–2014)
Vakin V.S., Amosova I.V., Vojcekhovskaya E.M., Timoshicheva T.A., Vasileva A.A., Pozdnyakova M.G., Lyalina L.V., Marchenko V.A., Nikonorov I.Y., Grudinin M.P.
Lung memory T-cell response in mice following intranasal immunization with influenza vector expressing mycobacterial proteins
Shurygina A.S., Zabolotnykh N.V., Vinogradova T.I., Vasilyev K.A., Buzitskaya Z.V., Stukova M.A.
IMMUNOGENICITY OF ADJUVANT INFLUENZA VACCINE FOR PREGNANT WOMEN
Kostinov M.P., Cherdantsev A.P., Shmitko A.D., Praulova D.A., Protasov A.D., Dagil U.A., Kostinova T.A., Akhmatova N.K., Chromova E.A., Ryzhov A.A., Blagovidov D.A., Polishchuk V.B., Magarshak O.O., Korovkina E.S.
REGIONAL VACCINATION PROGRAM FOR THE PREVENTION OF HPV-ASSOCIATED DISEASES IN THE KHMAO-YUGRA
Belotsercovtseva L.D., Mayer Y.I., Leskova S.V.
Safety and effectiveness of single- versus double-dose of seasonal influenza vaccine in kidney transplant recipients: a randomized clinical trial
Meidani M., Khatami M., Abdollahi A., Mirzapour P., Karimian E., SeyedAlinaghi S.
Influenza vaccination influencing level of specific humoral immunity in healthy individuals
Krivitskaya V.Z., Kuznecova E.V., Maiorova V.G., Petrova E.R., Sominina A.A., Danilenko D.M.
Meta-analysis of the effectiveness of pentavalent live oral vaccine for the prevention of severe forms of rotavirus gastroenteritis in children
Kosova A.A., Bashkirova E.S., Mashin T.I., Chalapa V.I.
IMMUNOGENICITY OF THE THIRD GENERATION HEPATITIS B VACCINE (pre-S1/pre-S2/S)
Esaulenko E.V., Sukhoruk A.A., Zakharov K.A., Yakovlev A.A.
THE CYTOKINES SYNTHESIS IN VITRO IN THE TICK-BORNE ENCEPHALITIS VIRUS INFECTED CELLS AND IN THE PRESENCE OF INACTIVATED VACCINE
Mesentseva M.V., Аntoshina I.F., Мorozova O.V.
Level of influenza virus strain antibodies in healthy vaccinated people at the end of the COVID-19 pandemic
Iushkova S.V., Kostinov M.P., Gladkova L.S., Kameleva A.A., Kachnova A.S., Kostinova A.M., Solovyeva I.L., Andreeva N.P., Dagil Y.A., Nastaeva N.Y., Kryukova N.O., Loktionova M.N.
Identifying correlates of protection from Yersinia pestis on a mouse model and assessing an opportunity for their use as markers of human vaccination efficiency
Klyueva S.N., Bugorkova S.A., Kashtanova T.
COVID-19 and BCG vaccine: is there a link?
Lyadova I.V., Starikov A.A.
PRODUCTION OF HYBRID RECOMBINANT PROTEIN Flu-Chim, CONTAINING INFLUENZA VIRUSES A AND B MAJOR EPITOPES
Dukhovlinov I.V., Dobrovolskaia O.A., Orlov A.I.
THE CELLS WITH MYCOBACTERIA IN GRANULOMATOUS AGGREGATES FROM MICE WITH LATENT TUBERCULOUS INFECTION IN EX VIVO CULTURE
Ufimtseva E.G.
Optimized properties of live vaccine influenza reassortant strains obtained by reverse genetics
Larionova N.V., Kiseleva I.V., Bazhenova E.A., Stepanova E.A., Rudenko L.G.
Generation and evaluation of specific activity and authenticity of recombinant vaccine designed preventing against Pseudomonas aeruginosa
Kaloshin A.A., Zimina E.M., Kalinichenko E.O., Mihailova N.A.
Detecting specific memory t and b cells in volunteers annually revaccinated with live anthrax vaccine
Firstova V.V., Kartseva A.S., Silkina M.V., Marin M.A., Muntian I.O., Ryabko A.K., Shemyakin I.G.
LIVING MICROORGANISM’S STABILYZATION IN BIOMASS BIOTECHNOLOGY AND PLAGUE VACCINE PREPARATION
Budika D.A., Abzaeva N.V., Gostischeva S.E., Rakitina E.L., Ivanova G.F., Fisun A.A.
THE EVALUATION OF REACTOGENICITY, SAFETY AND IMMUNOGENICITY OF THE POLYSACCHARIDE PNEUMOCOCCAL VACCINE DURING THE IMMUNIZATION OF HEALTH CARE WORKERS
Feldblum I.V., Golodnova S.O., Semerikov V.V., Nikolenko V.V., Metelkina N.A.
Virus neutralizing antibodies in pseudovirus particle neutralization reaction as a bioanalytical part of a Salnavac® vaccine clinical trial
Zuev E.V., Markova O.A., Kulemzin S.V., Poteryaev D.A., Litvinova N.A., Korotkevich I.A., Grigiryeva T.V., Khamitov R.A.
Features of immune response against influenza infection in animals vaccinated with recombinant cross-protective vaccine
Tsybalova L.M., Stepanova L.A., Korotkov A.V., Shuklina M.A., Zaitseva M.V., Grishchenko V.I., Kotlyarov R.Y.
HUMAN PAPILLOMA VIRUS IMMUNOGEN CREATION ON THE BASE OF CHIMERIC RECOMBINANT PROTEIN L2E7
Malakhov I.S., Al-Shehadat R.I., Duckhovlinov I.V., Simbirtsev A.S.
CLINICAL TRIAL OF THE PANDEMIC INFLUENZA MONOVALENT VACCINE PANDEFLU
Erofeeva M.K., Maksakova V.L., Nickonorov I.Y., Pozdnyakova M.G., Kotova O.S., Okhapkina E.A., Evgrafov V.D., Voicehovskaya E.M., Vasilyeva A.A., Stukova M.A., Bushmenkov D.S., Romanova A.A., Kiselev O.I.
Various reagent kits for comparatively analyzed effectiveness of humoral immune response after vaccination “Sputnik V"
Kazakov S.P., Reshetnyak D.V., Davydova N.V., Efimushkina О.А., Putkov S.B.
A single blind, placebo-controlled randomized study of the safety, reactogenicity and immunogenicity of the “EpiVacCorona” Vaccine for the prevention of COVID-19, in volunteers aged 18–60 years (phase I–II)
Ryzhikov A.B., Ryzhikov Е.А., Bogryantseva M.P., Usova S.V., Danilenko E.D., Nechaeva E.A., Pyankov O.V., Pyankova O.G., Gudymo A.S., Bodnev S.A., Onkhonova G.S., Sleptsova E.S., Kuzubov V.I., Ryndyuk N.N., Ginko Z.I., Petrov V.N., Moiseeva A.A., Torzhkova P.Y., Pyankov S.A., Tregubchak T.V., Antonec D.V., Gavrilova E.V., Maksyutov R.A.
Immunogenicity and protective efficacy of prime-boost immunization in mice vaccinated with live and inactivated influenza A (H5N1) vaccines
Losev I., Petukhova G., Isakova-Sivak I., Rudenko L.
CURRENT APPROACHES TO UNIVERSAL VACCINE AGAINST INFLUENZA VIRUS
Esmagambetov I.B., Alekseeva S.V., Sayadyan K.S., Shmarov M.M.
Induction of cross-reactive antibodies in mice immunized with conserved influenza A virus neuraminidase-derived linear B-cell epitopes
Sychev I.A., Kopeikin P.M., Tsvetkova E.V., Cheredova K.V., Milman B.L., Shamova O.V., Isakova-Sivak I.N., Desheva Y.A.
Measles vaccination of children born to HIV-infected mothers (clinical and immunological aspects)
Snegova N.F., Kostinov M.P., Pakhomov D.V., Ilina N.I.
DEVELOPMENT OF FUSION RECOMBINANT PROTEINS BASED ON VP6 AND VP8 OF HUMAN ROTAVIRUS A
Dukhovlinov I.V., Bogomolova E.G., Fedorova E.A., Simbirtsev A.S.
Comparative analysis of the conservation of nucleoprotein immunogenic T-cell epitopes of master donor viruses for live and inactivated influenza vaccines
Rak A.Y., Rudenkо L.G., Isakova-Sivak I.N.
Local and systemic adverse reactions following COVID-19 vaccine
Zherebtsova N.Y., Kajdanek T.V.
Safety of dengue vaccine (CYD-TDV) in Asia: a systematic review
Wan Ismail W.R., Abdul Majid M.S., Li H.Y., Madrim M.F., Abdul Rahim S.S., Jeffree M.S., Azhar Z.I., Ghazi H.F., Hassan M.R.
PERTUSSIS INCIDENCE AND THE EFFECT OF REVACCINATION OF PRESCHOOL AND SCHOOL CHILDREN
Kostinov А.M., Kostinov M.P.
DIFFERENT CHARACTERISTICS OF INFECTION WITH MYCOBACTERIA IN GRANULOMA CELLS FROM MICE WITH LATENT TUBERCULOSIS INFECTION AND IN BONE MARROW AND PERITONEAL MACROPHAGES AFTER BCG VACCINE APPLICATION IN VITRO
Ufimtseva E.G.
1 - 40 of 40 Items

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default only articles containing all terms in the query are returned (i.e., AND is implied)
  • Combine multiple words with OR to find articles containing either term; e.g., education OR research
  • Use parentheses to create more complex queries; e.g., archive ((journal OR conference) NOT theses)
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing"
  • Exclude a word by prefixing it with - or NOT; e.g. online -politics or online NOT politics
  • Use * in a term as a wildcard to match any sequence of characters; e.g., soci* morality would match documents containing "sociological" or "societal"

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies